Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Baxter
Medtronic
Chubb
Express Scripts
Argus Health
Boehringer Ingelheim
Dow
Mallinckrodt

Generated: January 17, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Veledimex

« Back to Dashboard

US Patents for Veledimex

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Veledimex ➤ Try a Free Trial Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex Intrexon Corporation (Blacksburg, VA) ➤ Try a Free Trial
Veledimex ➤ Try a Free Trial Process of preparing chiral diacylhydrazine ligands Intrexon Corporation (Blacksburg, VA) ➤ Try a Free Trial
Veledimex ➤ Try a Free Trial Modified forms of Pseudomonas exotoxin A Intrexon Corporation (Blacksburg, VA) ➤ Try a Free Trial
Veledimex ➤ Try a Free Trial Crystalline diacylhydrazine and the use thereof Intrexon Corporation (Blacksburg, VA) ➤ Try a Free Trial
Veledimex ➤ Try a Free Trial Boron-containing diacylhydrazines Intrexon Corporation (Blacksburg, VA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Veledimex

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Veledimex Australia 2008263122 2027-05-29 ➤ Try a Free Trial
Veledimex Brazil PI0811348 2027-05-29 ➤ Try a Free Trial
Veledimex Canada 2689137 2027-05-29 ➤ Try a Free Trial
Veledimex China 101848887 2027-05-29 ➤ Try a Free Trial
Veledimex China 104761466 2027-05-29 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cerilliant
Accenture
Baxter
Daiichi Sankyo
Merck
Teva
McKinsey
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: